S2 Fig contains incorrectly duplicated panels. The authors have provided a corrected version here.
Supporting information
S2 Fig. Routine hematoxylin and eosin staining for examining muscle morphology.
Hematoxylin and eosin staining of TA tissue sections from treated C57BL6 mice with 2 μg PMO, 5 μg PNA and 5 μg 2′Ome PS by local injection at different time-points e.g. 48 hr, 2 and 4 weeks after injection, and C57BL6 normal controls. Scale Bar = 100 μm. No difference was observed between treated and untreated mdx mice.
https://doi.org/10.1371/journal.pone.0207817.s001
(TIF)
Reference
- 1. Cao L, Han G, Gu B, Yin H (2014) Wild-Type Mouse Models to Screen Antisense Oligonucleotides for Exon-Skipping Efficacy in Duchenne Muscular Dystrophy. PLoS ONE 9(11): e111079. https://doi.org/10.1371/journal.pone.0111079 pmid:25365558
Citation: Cao L, Han G, Gu B, Yin H (2018) Correction: Wild-Type Mouse Models to Screen Antisense Oligonucleotides for Exon-Skipping Efficacy in Duchenne Muscular Dystrophy. PLoS ONE 13(11): e0207817. https://doi.org/10.1371/journal.pone.0207817
Published: November 15, 2018
Copyright: © 2018 Cao et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.